Literature DB >> 2166548

Folate-binding proteins.

G B Henderson1.   

Abstract

Folate-binding proteins of three major classes have been observed in various bodily fluids and in the plasma membrane and cytoplasm of normal and neoplastic cells. A major class, the high-affinity folate-binding proteins, show a preferential and tight binding of folic acid relative to reduced folates and methotrexate and consist of water-soluble and membrane-associated forms. Soluble forms of the high-affinity binders are present in serum and milk and in the growth medium of certain cultured cell lines, whereas membrane-associated forms are observed on the surface of various cells and tissues. The binders in serum have no clearly defined function, whereas the milk binders serve to accumulate and stabilize reduced-folate compounds in milk and they may also facilitate the absorption of folates by the intestinal mucosa of neonates. Membrane-bound forms of high-affinity folate-binding proteins mediate the transport of folate compounds across plasma membranes and appear to utilize endocytosis as the transport mechanism. Membrane-associated high-affinity binding proteins contain covalently bound phospholipids and hydrophobic C-terminal amino acid sequences that are absent in the soluble forms. The remaining protein portions of these binders show considerable sequence homology. The second class is composed of folate-binding proteins that reside solely in the plasma membrane and are structurally and mechanistically distinct from the high-affinity binders. These proteins function in transport, exhibit varied substrate specificities that accommodate reduced-folate compounds with equal or higher affinity than folate, and do not utilize endocytosis as the mechanism for substrate internalization. The third class of folate-binding proteins consists of enzymes that reside in the cytoplasm of cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166548     DOI: 10.1146/annurev.nu.10.070190.001535

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  27 in total

1.  CSF 5-Methyltetrahydrofolate Serial Monitoring to Guide Treatment of Congenital Folate Malabsorption Due to Proton-Coupled Folate Transporter (PCFT) Deficiency.

Authors:  A Torres; S A Newton; B Crompton; A Borzutzky; E J Neufeld; L Notarangelo; G T Berry
Journal:  JIMD Rep       Date:  2015-05-26

2.  Tissue-specific promoters of the alpha human folate receptor gene yield transcripts with divergent 5' leader sequences and different translational efficiencies.

Authors:  S J Roberts; K N Chung; K Nachmanoff; P C Elwood
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.

Authors:  G B Henderson; C A Stein
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

4.  The folate receptor works in tandem with a probenecid-sensitive carrier in MA104 cells in vitro.

Authors:  B A Kamen; A K Smith; R G Anderson
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Authors:  K N Chung; Y Saikawa; T H Paik; K H Dixon; T Mulligan; K H Cowan; P C Elwood
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome.

Authors:  Vincent T Ramaekers; Jeffrey M Sequeira; Nenad Blau; Edward V Quadros
Journal:  Dev Med Child Neurol       Date:  2008-03-19       Impact factor: 5.449

7.  Transfection of a glycosylated phosphatidylinositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium.

Authors:  C A Luhrs; C A Raskin; R Durbin; B Wu; E Sadasivan; W McAllister; S P Rothenberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  [6S]-5-Methyltetrahydrofolate enhances folate status in rats fed growing-up milk.

Authors:  Darío Pérez-Conesa; Juan Francisco Haro-Vicente; Fernando Romero Braquehais; Gaspar Ros
Journal:  Eur J Nutr       Date:  2009-04-23       Impact factor: 5.614

9.  Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis.

Authors:  J Wolf; T Stranzl; M Filipits; G Pohl; R Pirker; B Leeb; J S Smolen
Journal:  Ann Rheum Dis       Date:  2004-09-02       Impact factor: 19.103

10.  Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.

Authors:  P Garin-Chesa; I Campbell; P E Saigo; J L Lewis; L J Old; W J Rettig
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.